NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $245,000 | +118.8% | 93,684 | +37.8% | 0.00% | – |
| Q4 2018 | $112,000 | -77.3% | 67,969 | -33.4% | 0.00% | – |
| Q3 2018 | $494,000 | +48.3% | 102,038 | +91.4% | 0.00% | – |
| Q2 2018 | $333,000 | -27.1% | 53,302 | -3.2% | 0.00% | – |
| Q1 2018 | $457,000 | -50.8% | 55,041 | -39.5% | 0.00% | -100.0% |
| Q4 2017 | $928,000 | +71.5% | 90,992 | +53.8% | 0.00% | – |
| Q3 2017 | $541,000 | +58.2% | 59,156 | +26.3% | 0.00% | – |
| Q2 2017 | $342,000 | +6.2% | 46,853 | +4.9% | 0.00% | – |
| Q1 2017 | $322,000 | +23.4% | 44,685 | 0.0% | 0.00% | – |
| Q4 2016 | $261,000 | -12.1% | 44,685 | -1.1% | 0.00% | – |
| Q3 2016 | $297,000 | -29.1% | 45,174 | 0.0% | 0.00% | – |
| Q2 2016 | $419,000 | +142.2% | 45,174 | +181.9% | 0.00% | – |
| Q1 2016 | $173,000 | -24.5% | 16,023 | 0.0% | 0.00% | – |
| Q4 2015 | $229,000 | -32.0% | 16,023 | 0.0% | 0.00% | – |
| Q3 2015 | $337,000 | – | 16,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,962,657 | $3,100,000 | 2.37% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $62,000 | 0.02% |
| SlateStone Wealth, LLC | 62,000 | $39,000 | 0.01% |
| Allred Capital Management, LLC | 24,995 | $15,000 | 0.01% |
| Bridge Advisory, LLC | 23,564 | $15,000 | 0.01% |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 24,000 | $15,000 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $201,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 229,500 | $143,000 | 0.00% |
| Virtu Financial LLC | 41,401 | $26,000 | 0.00% |
| TSFG, LLC | 200 | $1,000 | 0.00% |